相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neuregulin 1 (NRG1) fusion-positive high-grade spindle cell sarcoma: A distinct group of soft tissue tumors with metastatic potential
Josephine K. Dermawan et al.
GENES CHROMOSOMES & CANCER (2022)
Identification of tumors with NRG1 rearrangement, including a novel putative pathogenic UNC5D-NRG1 gene fusion in prostate cancer by data-drilling a de-identified tumor database
Nikola Ptakova et al.
GENES CHROMOSOMES & CANCER (2021)
The Anti-HER3 mAb Seribantumab Effectively Inhibits Growth of Patient-Derived and Isogenic Cell Line and Xenograft Models with Oncogenic NRG1 Fusions
Igor Odintsov et al.
CLINICAL CANCER RESEARCH (2021)
Novel Preclinical Patient-Derived Lung Cancer Models Reveal Inhibition of HER3 and MTOR Signaling as Therapeutic Strategies for NRG1 Fusion-Positive Cancers
Igor Odintsov et al.
JOURNAL OF THORACIC ONCOLOGY (2021)
Efficacy and safety of zenocutuzumab in advanced pancreas cancer and other solid tumors harboring NRG1 fusions.
Alison M. Schram et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-I
Johannes Braegelmann et al.
NATURE COMMUNICATIONS (2021)
A phase II basket study of MCLA-128, a bispecific antibody targeting the HER3 pathway, in NRG1 fusion-positive advanced solid tumors.
Alison M. Schram et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Detection of NRG1 Gene Fusions in Solid Tumors
Sushma Jonna et al.
CLINICAL CANCER RESEARCH (2019)
NRG1 Gene Fusions Are Recurrent, Clinically Actionable Gene Rearrangements in KRAS Wild-Type Pancreatic Ductal Adenocarcinoma
Martin R. Jones et al.
CLINICAL CANCER RESEARCH (2019)
Response to ERBB3-Directed Targeted Therapy in NRG1-Rearranged Cancers
Alexander Drilon et al.
CANCER DISCOVERY (2018)
NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer
Christoph Heining et al.
CANCER DISCOVERY (2018)
Durable Response to Afatinib in Lung Adenocarcinoma Harboring NRG1 Gene Fusions
Nathan D. Gay et al.
Journal of Thoracic Oncology (2017)
Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline Carcinoma
Johannes Braegelmann et al.
CELL REPORTS (2017)
Successful targeting of the NRG1 pathway indicates novel treatment strategy for metastatic cancer
M. R. Jones et al.
ANNALS OF ONCOLOGY (2017)
Oncogenic Fusion Gene CD74-NRG1 Confers Cancer Stem Cell-like Properties in Lung Cancer through a IGF2 Autocrine/Paracrine Circuit
Takahiko Murayama et al.
CANCER RESEARCH (2016)
Overcoming resistance to HER2 inhibitors through state-specific kinase binding
Chris J. Novotny et al.
NATURE CHEMICAL BIOLOGY (2016)
CD74-NRG1 Fusions in Lung Adenocarcinoma
Lynnette Fernandez-Cuesta et al.
CANCER DISCOVERY (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
Timothy R. Wilson et al.
NATURE (2012)
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Bo Li et al.
BMC BIOINFORMATICS (2011)
Neuregulin 1 in neural development, synaptic plasticity and schizophrenia
Lin Mei et al.
NATURE REVIEWS NEUROSCIENCE (2008)
Neuregulins: functions, forms, and signaling strategies
DL Falls
EXPERIMENTAL CELL RESEARCH (2003)
分享论文
